Choice Hotels Short Sellers Ease Back as Stock Jumps 9%
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Short sellers in CHH have trimmed positions even as the stock posted one of its stronger weeks in recent memory, a combination that puts the lending market and price action briefly on the same side of the ledger.
Short interest in Choice Hotels has pulled back from a peak of roughly 7.1 million shares on October 1 to about 5.9 million now, a decline of around 16% over three weeks. That leaves short interest at 12.8% of the free float, still high enough to rank in the third percentile of the ORTEX universe on the short score factor, meaning very few stocks carry a heavier short burden relative to their size. The ORTEX short score of 77.8 has eased slightly from a week ago, when it briefly touched 80, but remains elevated. Borrow costs have also retreated sharply, down about 20% over the past week to 1.4%, after a brief spike to 18.8% on October 1 that pointed to a very tight lending pool at the end of last month. Availability has since loosened considerably, recovering from a low of just 16% on October 1 to 136% now, meaning there are roughly 12 million shares available to borrow for every 5.9 million already out on loan. The borrow market has gone from near-closed to comfortable in three weeks.
Options positioning tells a different story from the easing short interest. The put/call ratio has surged to 1.99, almost 2.8 standard deviations above its 20-day average of 0.77, and is approaching its 52-week high of 2.66. That is a sharp reversal from early October, when the ratio was sitting below 0.4. Options traders have moved decisively toward downside protection even as the stock rallied 9.2% over the past week to $113.46. The contrast between short sellers lightening up and options desks loading on puts is the most interesting tension in the current setup.
The analyst community has been busy this week but the direction is not straightforwardly bullish. JP Morgan raised its target to $121 from $119 on Tuesday while keeping a Neutral rating, and earlier this week Wells Fargo lifted its target by a dollar to $98, also holding Underweight. Barclays and Morgan Stanley both made similarly token increases to bearish targets, $103 and $92 respectively. The mean price target across the Street is $114.94, almost exactly where the stock is trading now, which leaves the consensus implying very little upside. The lone new initiation this week, from Freedom Broker at a $117 Buy, offers a slightly more optimistic read, and Truist and Baird both carry targets above $128. The divergence between optimists and pessimists on the Street is unusually wide, with Morgan Stanley's $92 target and Truist's $129 about as far apart as the hotels sector typically gets. Valuation is not obviously cheap at a P/E of 15.3 and EV/EBITDA of 10.8, both up slightly over the past month as the share price has re-rated. The dividend score ranks in the 94th percentile but the last dividend event in the dataset dates back to 2022, so that ranking likely reflects the historical yield structure rather than a current payment.
Ownership concentration is a structural feature worth noting. Baron Capital Group holds 20.9% of shares as last reported, making it the dominant outside shareholder. The founding Bainum family entities collectively account for another 30% or more of outstanding shares through several separate holdings. That concentration limits the effective float and is part of why even a relatively modest short position of 5.9 million shares translates to 12.8% of the free float. Baron added 1.6 million shares in the most recent reported period, while Eaton Vance trimmed by 384,000. Morgan Stanley's 13G shows a stake of 6.3%, down from 7.6%, and Vanguard's most recent 13G/A filing shows it has exited entirely, having previously held 5%. All 13D/G positions are as last disclosed and holders crossing below the 5% threshold may not file again.
On the insider side, CEO Dominic Dragisich sold 1,227 shares on October 20 at $112, a $137,000 transaction executed under a pre-arranged 10b5-1 plan. Planned sales carry less signal than discretionary ones. The same day and the prior week saw a cluster of small share awards to directors and other officers, routine compensation grants rather than market transactions.
CHH's next earnings release is scheduled for November 2. The two most recent quarterly prints produced a 1% gain on the day of the August report and a 3.6% decline on the July print, with both giving back additional ground over the following five days. The November 2 print will update the picture on whether the short covering that started in early October reflects a change in bearish conviction or simply position management ahead of results.
Stocks in this article
See the live data behind this article on ORTEX.
Open CHH on ORTEX →How this article was generated
- Generated
- 21 Oct 2026, 18:15
- Data as of
- 21 Oct 2026, 18:15
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.